Live Breaking News & Updates on Health Program Updates
Stay updated with breaking news from Health program updates. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Company receives further regulatory clarity from FDA on Phase 3 ENABLAR-2 study. Potential for enobosarm +/- abemaciclib accelerated approval pathway in metastatic breast cancer, if successful based. -Today at 06:31 am- MarketScreener ....
Sabizabulin for moderate to severe COVID-19 under review for potential emergency authorization by multiple global regulatory agencies Presented late-breaker oral presentation at IDWeek; sabizabulin treatment ....